(90 days)
Becton Dickinson Home Sharps Container
Not Found
No
The device description and intended use are purely mechanical, focusing on storage and dispensing of syringes and safe disposal of sharps. There is no mention of any computational or analytical functions that would suggest AI/ML.
No
The device is a dispenser and sharps container for insulin syringes, designed for storage and disposal, not for directly treating a medical condition.
No
Explanation: The device is a dispenser and sharps container for insulin syringes, designed for storage and disposal of used syringes, not for diagnosing medical conditions.
No
The device description clearly indicates it is a physical container designed to store and dispense syringes and store used sharps, not a software application.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. They are used to provide information for diagnosis, monitoring, or screening.
- Device Function: The Ulti Guard Home Insulin Syringe Dispenser and Sharps Container is a device for storing, dispensing, and safely disposing of insulin syringes. It does not perform any tests on biological samples. Its function is purely related to the handling and containment of medical sharps.
The provided information clearly describes a device for managing insulin syringes, not for performing diagnostic tests.
N/A
Intended Use / Indications for Use
The Ulti Guard Home Insulin Syringe Dispenser and Sharps Container by Ulti Med Inc. is a intended to be used to transport, store and disponse UltiCare insulin syringes in the home. After use the UltiCare insulin syringes are deposed into the Ulti Guard container for safe storage and eventual disposal according to local regulations.
Product codes
MMK
Device Description
Ulti Guard Home syringe contains 100 UltiCare insulin syringes. Syringes can be selectively removed as needed, and used syringes conveniently deposited back into the top of the container for safe storage. Ulti Guard syringes and container are single use only.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
home
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The Ulti Guard Home Insulin Syringe Dispenser and Sharps Container has been tested with acceptable results for Impact Resistance, Puncture Resistance, Leak Resistance Sharps Access and Stability.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Becton Dickinson Home Sharps Container
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5570 Hypodermic single lumen needle.
(a)
Identification. A hypodermic single lumen needle is a device intended to inject fluids into, or withdraw fluids from, parts of the body below the surface of the skin. The device consists of a metal tube that is sharpened at one end and at the other end joined to a female connector (hub) designed to mate with a male connector (nozzle) of a piston syringe or an intravascular administration set.(b)
Classification. Class II (performance standards).
0
SEP 1 6 2002
510(k) Number: K021983 UltiGuard Home Insulin Syringe Dispenser and Sharps Container
510(k) Summary of Safety and Effectiveness
-
- The submitter of this submission is: Ulti Med Inc. 287 E. Sixth Street St. Paul, MN 55101 Telephone (651) 291-7909 Fax (651) 291-7074
The contact person is: Charles W. Erickson e-mail: c.erickson@ulti-care.com
- The submitter of this submission is: Ulti Med Inc. 287 E. Sixth Street St. Paul, MN 55101 Telephone (651) 291-7909 Fax (651) 291-7074
On this 10th day of September, 2002.
-
- The trade name of the package shall be "Ulti Guard Home Insulin Syringe Dispenser and Sharps Container".
- The Ulti Guard Home Insulin Syringe Dispenser and Sharps Container has the 3) comparable intended use as the pre marketed Becton Dickinson Home Sharps Container.
-
- The Ulti Guard Home Insulin Syringe Dispenser and Sharps Container has been tested with acceptable results for Impact Resistance, Puncture Resistance, Leak Resistance Sharps Access and Stability.
- Ulti Guard Home syringe contains 100 UltiCare insulin syringes. Syringes can 5) be selectively removed as needed, and used syringes conveniently deposited back into the top of the container for safe storage. Ulti Guard syringes and container are single use only.
- The intended use is for the storage and disposal of insulin syringes. 6)
- The UltiGuard Home syringe container differs from the predicate device as the disposal 7) container is sold with the syringes. As syringes are removed and used, the container has the purpose of safely storing the used syringes. This promotes the convenient and safe disposal of used syringes in the home.
1
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is an abstract symbol that resembles a stylized caduceus or a representation of human figures.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
SEP 1 6 2002
Mr. Charles Erickson President Ulti Med, Incorporated 287 East Sixth Street Saint Paul, Minnesota 55101
Re: K021983
Trade/Device Name: Ulti Guard Home Insulin Syringe Dispenser and Sharps Container Regulation Number: 880.5570 Regulation Name: Hypodermic Single Lumen Needle Regulatory Class: II Product Code: MMK Dated: August 28, 2002 Received: August 29, 2002
Dear Mr. Erickson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
2
Page 2 - Mr. Erickson
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4618. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.qov/cdrh/dsma/dsmamain.html
Sincerely yours,
Suain Ranes
ヶ Timothy A. Ulatowski Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
510(k) Number: K021983 UltiGuard Home Insulin Syringe Dispenser and Sharps Container
Indication of Use Statement
The Ulti Guard Home Insulin Syringe Dispenser and Sharps Container by Ulti Med Inc. is a The Ulti Guard Home Insultif Syrings Disponse insulins viringes in the home. After use the intended to be used to transport, store and disponse thanks of to be and eventual disposal according to local regulations.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use X (Pcr 21 CFR 801.109)
OR
Over-The-Counter Use
(Optional Format 1-2-96)
Riu li tai lin
(Division Sign-Off) Division of Anesthesiology, General Hospital, Infection Control, Dental Devices
510(k) Number. KC 3 19 8 3